ArticleFrontiers in allergy2025

Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthma.

Ayobami Akenroye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.